Vidrala (BME:VID) Stock Faces Margin Compression As 12.2% Net Margin Challenges Bullish Narrative
Vidrala (BME:VID) has released its H1 2026 update with trailing 12 month revenue of €1.5b and basic EPS of €6.03, setting a clear benchmark for how the business is currently earning on its glass packaging operations. Over recent periods the company has seen revenue move from €1.62b in H2 2024 to €1.54b in H1 2025, then to €1.51b in H2 2025 and €1.52b in H1 2026, while basic EPS tracked from €6.73 to €6.66, €5.95 and €6.03 across the same halves, giving investors a consistent data trail on both the top and bottom line. With trailing net profit margins softer than last year, this earnings release puts profitability quality and future margin resilience at the center of the Vidrala story.
See our full analysis for Vidrala.With the numbers on the table, the next step is to see how these results line up with the prevailing market narratives about Vidrala and where those stories might be pressured by the latest trends.
See what the community is saying about Vidrala
Margins Slip From 15.2% To 12.2%
- Trailing net profit margin is 12.2%, down from 15.2% a year earlier, alongside trailing 12 month net income excluding extra items of €185.4 million on €1.52b of revenue.
- Critics highlight that weaker end-market demand and regulatory costs could pressure margins further, and the recent margin decline gives that bearish view some backing, yet:
- Consensus narrative also points to investments in automation and energy efficiency that are intended to support operating margins. This sits in contrast to the recent compression from 15.2% to 12.2%.
- Analysts assume margins can reach 16.5% over time, so the current 12.2% level leaves a noticeable gap between recent history and the more optimistic margin path described in the bullish story.
Revenue Soft Patch With EPS Holding
- On a half year basis, Vidrala’s revenue moved from €844.7 million in H1 2024 to €768.0 million in H1 2025 and €743.8 million in H2 2025, while basic EPS over those halves came in at €3.14, €3.06 and €2.88 respectively, showing earnings remaining in a similar range despite lower sales.
- Analysts' consensus view suggests that investments in automation, recycled materials and energy efficiency support earnings resilience even when like for like revenue declined 6.7%, and the recent pattern of softer revenue with steady EPS speaks to that tension:
- Consensus narrative argues that cost improvements and higher recycled glass usage help keep profitability intact. This is consistent with EPS staying above €2.80 per half across 2024 and 2025 even as revenue per half moved down from €844.7 million to €743.8 million.
- At the same time, the revenue drift lower and comments about weaker volumes in key European markets show why some investors question how long these efficiency gains can counter softer demand.
Valuation Gap And 16.3x P/E
- Vidrala trades on a trailing P/E of 16.3x versus a peer average of 12.5x and a Global Packaging industry average of 16.6x, while the current share price of €86.00 sits below both a DCF fair value of €166.39 and an analyst price target of €103.79.
- Bears argue that paying a premium P/E versus peers is hard to justify if margins stay at 12.2% and revenue growth runs at around 2% a year, yet several datapoints temper that cautious take:
- The stock price is well below the DCF fair value of €166.39 and below the €103.79 price target, so the market is not fully reflecting the more optimistic earnings path that would line up with those values.
- Forecast earnings growth of about 11.3% per year and five year compound earnings growth of 8.8% per year sit behind the valuation work. This stands in contrast to the recent trailing period where earnings were weaker year over year.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Vidrala on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
With sentiment mixed around Vidrala's margins, valuation and revenue trend, it makes sense to move quickly and check the underlying data for yourself. To see how the current optimism around the company compares with the detailed numbers, take a closer look at the 4 key rewards.
See What Else Is Out There
Vidrala's softer margins, easing revenue and premium 16.3x P/E against peers highlight that earnings quality and valuation are both under pressure in the current narrative.
If you are concerned about paying up for that kind of uncertainty, it is worth quickly checking companies that look cheaper on the numbers using the 236 high quality undervalued stocks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About BME:VID
Vidrala
Engages in the manufacture and sale of glass containers for food and beverage products in the United Kingdom, Ireland, Italy, Iberian Peninsula, rest of Europe, and Brazil.
Undervalued with excellent balance sheet and pays a dividend.
Similar Companies
Market Insights
Weekly Picks

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Zoetis down -50% over the past year

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.
Recently Updated Narratives
ASML Will Reign as the Kingpin of the Semiconductor Supply Chain
Fortinet, compounding Cyber Security Player.
Constellation Software: A Proven Serial Acquirer at a Discount
Popular Narratives
PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback
A wonderful business at reasonable price.




